Hepatitis A Vaccine ( DrugBank: Hepatitis A Vaccine )

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	4
96	クローン病	1
97	潰瘍性大腸炎	1

46. 悪性関節リウマチ

臨床試験数 : 4,325 / 薬物数 : 2,671 - (DrugBank : 417) / 標的遺伝子数 : 187 - 標的パスウェイ数 : 224

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01947465 (ClinicalTrials.gov)	October 2013	22/8/2013	Immunogenicity and Safety of Vaccinations in Immunocompromised Persons	A Prospective Cohort Study in 6 Swiss Rheumatology Centres and 4 Travel Clinics on the Immunogenicity and Safety of Tetanus and Hepatitis A Vaccine in Patients With Rheumatoid Arthritis, Axial Spondyloarthritis and Vasculitis and Healthy Controls	Arthritis, Rheumatoid;Spondylarthritis;Vasculitis	Biological: Hepatitis A vaccine and tetanus vaccine	University of Zurich	University of Basel;Swiss Tropical & Public Health Institute;University of Bern;University Hospital, Geneva;Cantonal Hospital of St. Gallen;Cantonal Hospital of Aarau, Switzerland	Completed	18 Years	N/A	Both	645	N/A	Switzerland
2	NCT01446978 (ClinicalTrials.gov)	September 2011	3/10/2011	Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs	Hepatitis A Vaccination in Patients With Rheumatoid Arthritis Treated With TNF-inhibitors and/or Methotrexate	Vaccine Response Impaired	Biological: hepatitis A vaccine	Sormland County Council, Sweden	NULL	Active, not recruiting	18 Years	N/A	Both	150	Phase 2	Sweden
3	EUCTR2009-016055-22-SE (EUCTR)	09/03/2011	11/01/2011	Hepatitis A vaccine in patients with immunomodulative drugs	Hepatitis A vaccine in patients with immunomodulative drugs	Patients with rheumatoid arthritis treated with immunosuppressive medication MedDRA version: 12.1;Level: LLT;Classification code 10039073;Term: Rheumatoid arthritis MedDRA version: 12.1;Classification code 10054980;Term: Immunosuppressant drug therapy MedDRA version: 12.1;Classification code 10063430;Term: Hepatitis A immunisation	Trade Name: Epaxal Product Name: Epaxal Other descriptive name: Inactivated hepatitis A virus Trade Name: Havrix Product Name: Havrix Other descriptive name: inactivated hepatitis A virus	HY, HUS	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	380		Finland;Sweden
4	NCT01360970 (ClinicalTrials.gov)	September 2009	24/5/2011	Hepatitis A Vaccine in Patients With Immunomodulating Drugs	Hepatitis A Vaccination in Patients With Rheumatoid Arthritis Treated With TNF-inhibitors and/or Methotrexate	Response to Hepatitis A Vaccine	Biological: hepatitis A vaccine ( HAVRIX or EPAXAL)	Lars Rombo	NULL	Completed	18 Years	N/A	Both	68	Phase 2	Finland;Sweden

96. クローン病

臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01341808 (ClinicalTrials.gov)	April 2011	25/4/2011	Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients	Immunogenicity of Hepatitis A Vaccine in Patients With Inflammatory Bowel Disease	Inflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis;Hepatitis A	Biological: Epaxal Berna (virosomal hepatitis A vaccine)	Asan Medical Center	NULL	Completed	18 Years	40 Years	Both	493	Phase 4	Korea, Republic of

97. 潰瘍性大腸炎

臨床試験数 : 2,527 / 薬物数 : 1,465 - (DrugBank : 259) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01341808 (ClinicalTrials.gov)	April 2011	25/4/2011	Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients	Immunogenicity of Hepatitis A Vaccine in Patients With Inflammatory Bowel Disease	Inflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis;Hepatitis A	Biological: Epaxal Berna (virosomal hepatitis A vaccine)	Asan Medical Center	NULL	Completed	18 Years	40 Years	Both	493	Phase 4	Korea, Republic of

先頭へ